Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.94% |
| 2 | Technology | 8.23% |
| 3 | Healthcare | 7.53% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
ALX Oncology
ALXO
$277M
| $986K | ﹤0.01% |
87,446
-144,716
| -62% | -$1.63M |
|
|
TRVG
4127
trivago
TRVG
$423M
| $985K | ﹤0.01% |
145,886
+11,476
| +9% | +$70.5K |
|
|
MREO
4128
Mereo BioPharma
MREO
$40.3M
| $984K | ﹤0.01% |
1,311,349
+57,738
| +5% | +$47.4K |
|
|
NOTE.WS
4129
CALL
DELISTED
FiscalNote Holdings Warrants
NOTE.WS
| $983K | ﹤0.01% |
799,218
| – | – |
|
4130
McEwen Inc
MUX
$1.25B
| $982K | ﹤0.01% |
167,621
+148,144
| +761% | +$689K |
|
4131
BioVie
BIVI
$18.3M
| $981K | ﹤0.01% |
+1,262
| New | +$682K |
|
|
AAT
4132
American Assets Trust
AAT
$1.38B
| $980K | ﹤0.01% |
36,987
-81,178
| -69% | -$2.2M |
|
4133
OceanFirst Financial
OCFC
$1.82B
| $980K | ﹤0.01% |
46,133
-178,513
| -79% | -$3.9M |
|
4134
CALL
Amylyx Pharmaceuticals
AMLX
$3.87B
| $979K | ﹤0.01% |
26,500
-144,800
| -85% | -$5.14M |
|
4135
Epsilon Energy
EPSN
$182M
| $979K | ﹤0.01% |
147,653
-30,835
| -17% | -$213K |
|
4136
iShares US Financials ETF
IYF
$4.31B
| $979K | ﹤0.01% |
12,973
+1,206
| +10% | +$90.4K |
|
|
SLAMU
4137
DELISTED
Slam Corp. Unit
SLAMU
| $978K | ﹤0.01% |
96,820
-42,742
| -31% | -$428K |
|
|
ITOS
4138
CALL
DELISTED
iTeos Therapeutics
ITOS
| $977K | ﹤0.01% |
+50,000
| New | +$977K |
|
4139
BRC Group Holdings
RILY
$283M
| $975K | ﹤0.01% |
28,503
+3,883
| +16% | +$163K |
|
|
FNCB
4140
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $975K | ﹤0.01% |
118,698
-25,340
| -18% | -$200K |
|
4141
Brady Corp
BRC
$4.39B
| $969K | ﹤0.01% |
20,582
-77,446
| -79% | -$3.55M |
|
4142
PUT
Molson Coors Class B
TAP
$7.73B
| $969K | ﹤0.01% |
18,800
| – | – |
|
|
BBT
4143
Beacon Financial Corp
BBT
$2.63B
| $968K | ﹤0.01% |
32,362
-73,995
| -70% | -$2.18M |
|
|
ONEM
4144
PUT
DELISTED
1Life Healthcare
ONEM
| $968K | ﹤0.01% |
57,900
-100
| -0.2% | -$1.69K |
|
4145
PUT
AdaptHealth
AHCO
$772M
| $967K | ﹤0.01% |
+50,300
| New | +$1.06M |
|
4146
iShares MSCI China ETF
MCHI
$6.25B
| $965K | ﹤0.01% |
20,320
-90,444
| -82% | -$3.92M |
|
4147
PUT
Elanco Animal Health
ELAN
$12B
| $964K | ﹤0.01% |
+78,900
| New | +$983K |
|
|
CMPS
4148
Compass Pathways
CMPS
$1.9B
| $962K | ﹤0.01% |
119,811
-77,204
| -39% | -$775K |
|
|
KG
4149
Kestrel Group
KG
$59.2M
| $962K | ﹤0.01% |
22,793
+5,598
| +33% | +$238K |
|
|
BRMK
4150
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $962K | ﹤0.01% |
+270,134
| New | +$1.26M |
|
Similar funds
Israel Englander's Q4 2022 Portfolio in Review
As of Q4 2022, Israel Englander held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander's Q4 2022 filing shows 848 new, 2,516 increased, 2,491 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Israel Englander added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Israel Englander's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Israel Englander fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Israel Englander's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Israel Englander opened 848 new positions and closed 1,332 in Q4 2022.
- Israel Englander's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.